Skip to content

Study of how pain relieving medications (opioids) can affect or be affected by other medications in cancer patients with pain

Exploring potential drug-drug interactions at cytochrome P450 level among patients with cancer related pain on opioids in a palliative care setting - a prospective observational study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068387
Enrollment
750
Registered
2024-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patent attending palliative opd and receiving opioid for cancer related pain

Exclusion criteria

Exclusion criteria: cancer patient with post operative and other procedure related pain

Design outcomes

Primary

MeasureTime frame
Identify DDIs at cytochrome P450 level between opioids and other drugs. Assess category of interactions Assess severity of interactionsTimepoint: 16th month

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Smita Shenoy

Kasturba Medical College , Manipal

smtshenoy@gmail.com9844559772

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026